ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $224,305 | -78.6% | 12,040 | -70.2% | 0.00% | – |
Q2 2023 | $1,049,228 | +0.8% | 40,386 | +11.5% | 0.00% | – |
Q1 2023 | $1,040,468 | -4.5% | 36,228 | -1.5% | 0.00% | – |
Q4 2022 | $1,089,191 | +28.6% | 36,797 | +3.4% | 0.00% | – |
Q3 2022 | $847,000 | +8.6% | 35,589 | +1.9% | 0.00% | – |
Q2 2022 | $780,000 | -10.9% | 34,926 | +0.2% | 0.00% | – |
Q1 2022 | $875,000 | -31.1% | 34,865 | -1.6% | 0.00% | – |
Q4 2021 | $1,270,000 | -12.5% | 35,424 | +3.8% | 0.00% | – |
Q3 2021 | $1,452,000 | +7.7% | 34,111 | +9.5% | 0.00% | – |
Q2 2021 | $1,348,000 | -19.0% | 31,139 | -23.5% | 0.00% | -100.0% |
Q1 2021 | $1,665,000 | -8.4% | 40,730 | +1.5% | 0.00% | 0.0% |
Q4 2020 | $1,817,000 | +28.4% | 40,140 | +0.4% | 0.00% | 0.0% |
Q3 2020 | $1,415,000 | -5.7% | 39,992 | +0.4% | 0.00% | 0.0% |
Q2 2020 | $1,501,000 | +40.1% | 39,844 | +7.5% | 0.00% | 0.0% |
Q1 2020 | $1,071,000 | -44.0% | 37,048 | +0.5% | 0.00% | 0.0% |
Q4 2019 | $1,911,000 | +3.0% | 36,856 | +9.1% | 0.00% | 0.0% |
Q3 2019 | $1,855,000 | +37.3% | 33,788 | +1.6% | 0.00% | 0.0% |
Q2 2019 | $1,351,000 | +32.5% | 33,245 | -1.4% | 0.00% | 0.0% |
Q1 2019 | $1,020,000 | +1.0% | 33,715 | +10.4% | 0.00% | 0.0% |
Q4 2018 | $1,010,000 | -23.6% | 30,543 | -2.6% | 0.00% | 0.0% |
Q3 2018 | $1,322,000 | +43.4% | 31,343 | +7.9% | 0.00% | 0.0% |
Q2 2018 | $922,000 | -31.9% | 29,039 | +6.5% | 0.00% | 0.0% |
Q1 2018 | $1,353,000 | -6.3% | 27,277 | +1.8% | 0.00% | 0.0% |
Q4 2017 | $1,444,000 | -8.3% | 26,797 | -1.3% | 0.00% | 0.0% |
Q3 2017 | $1,575,000 | +19.9% | 27,139 | +1.9% | 0.00% | 0.0% |
Q2 2017 | $1,314,000 | +25.7% | 26,636 | +10.6% | 0.00% | 0.0% |
Q1 2017 | $1,045,000 | -11.4% | 24,076 | -0.1% | 0.00% | 0.0% |
Q4 2016 | $1,180,000 | +103.1% | 24,106 | +97.7% | 0.00% | 0.0% |
Q3 2016 | $581,000 | +438.0% | 12,196 | +491.8% | 0.00% | – |
Q2 2016 | $108,000 | +17.4% | 2,061 | 0.0% | 0.00% | – |
Q1 2016 | $92,000 | +9.5% | 2,061 | -5.7% | 0.00% | – |
Q4 2015 | $84,000 | +21.7% | 2,186 | 0.0% | 0.00% | – |
Q3 2015 | $69,000 | -1.4% | 2,186 | 0.0% | 0.00% | – |
Q2 2015 | $70,000 | -22.2% | 2,186 | 0.0% | 0.00% | – |
Q1 2015 | $90,000 | +1.1% | 2,186 | 0.0% | 0.00% | – |
Q4 2014 | $89,000 | +9.9% | 2,186 | 0.0% | 0.00% | – |
Q3 2014 | $81,000 | – | 2,186 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |